Allowing for the A$500 million approximate debt of OMH, probably to date as OMH must still be paying down this debt, it would lead to a different analysis of the price relationship between WEC and OMH.
With JMS valuation at 2 billion shares at A$1.50 it is indeed A$6 billion for Tshipi. The iron ore assets and other income generation is not that significant at present.
On JMS valuation at 60c, with no debt and fully diluted = A$1.2 billion.
OMH with 770 million shares, with A$500m debt and a further 5% in options and warrants, creates a different picture. A valuation at A$1.25 = A$962.5 million.
So a valuation of JMS at 60c and A$1.2 billion means taking off the A$500m debts which makes it A$700m and allowing for OMH dilution is A$665m. That is purely comparing OMH with JMS.
We know that JMS is mainly a Manganese asset and OMH has Manganese and other Ferro interests. It is a matter of opinion as to whether JMS should IPO well above its A$0.44 buyback price due to be paid on 19th March.
- Forums
- ASX - By Stock
- JMS
- Maybe a good time to relist
Maybe a good time to relist, page-29
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JMS (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $313.6M |
Open | High | Low | Value | Volume |
16.0¢ | 16.3¢ | 16.0¢ | $781.2K | 4.880M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 152165 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 1077364 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 152165 | 0.160 |
25 | 3874576 | 0.155 |
30 | 5211396 | 0.150 |
13 | 743912 | 0.145 |
11 | 565714 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 1017364 | 10 |
0.170 | 917001 | 14 |
0.175 | 532932 | 8 |
0.180 | 1010835 | 12 |
0.185 | 204760 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
JMS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online